Overview

Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients

Status:
Active, not recruiting

Trial end date:
2021-07-30

Target enrollment:

Participant gender:

Summary

We aim to compare the response to ketamine/dexmedetomidine and ketamine/propofol combinations used in hepatic patients with child-Pugh classification (class A), and early (class B) undergoing UGIE.

Phase:

Phase 4

Details

Lead Sponsor:

Tamer Nabil Abdelrahman

Treatments:

Dexmedetomidine
Ketamine
Propofol